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Abstract Cellular angioﬁbroma is a benign vascular
neoplasm that typically arises in the vulva, perineal, and
paratesticular region. Microscopically the lesions exhibit
multiple small, non-dilated capillary channels, many of
which contain erythrocytes. The endothelial lining cells are
prominent, with monomorphic oval nuclei. Interposed
among the vessels are both delicate and mature collagen
ﬁbers with ﬁbroblastic hypercellularity that is variable in
older lesions where sclerosis is prominent. The lesions
usually do not recur following simple excision. Recent
evidence indicates that cellular angioﬁbromas may be
cytogenetically related to spindle cell lipoma. This repre-
sents the ﬁrst reported instances of cellular angioﬁbroma in
the oral cavity.
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Introduction
Vascular and ﬁbrous lesions are common in the head and
neck area including both benign and malignant subtypes.
Angioﬁbromas are typically encountered in the naso-
pharynx among teenage males, accounting for the
appellation ‘‘juvenile nasopharyngeal angioﬁbroma’’.
Recently another ﬁbrovascular lesion has been described
in the genital/perineal region among females that is dis-
tinctly different from juvenile nasopharyngeal
angioﬁbroma both histologically and behaviorally [1–8].
The term cellular angioﬁbroma has been applied to this
lesion which has also been found in the paratesticular
region among males and in skin [3, 9–12]. These benign
ﬁbrovascular tumors do not have a tendency to recur after
simple excision. No instances of cellular angioﬁbroma
have been reported in the head and neck area. Two
instances are reported herein. One case appears to repre-
sent an early cellular stage while the second case is
hypocellular with sclerosis.
Case Reports
Case 1: A 38 year old female presented with a submucosal
nodule in the soft palate thought to represent a salivary
neoplasm. The patient’s past medical history was non-
contributory. The lesion was removed by surgical biopsy.
The excised lesion measured 1.4 9 1.0 mm. Microscopi-
cally, surface stratiﬁed squamous epithelium was present
with an underlying well demarcated and partially encap-
sulated mass of ﬁbrovascular connective tissue (Fig. 1a, b).
The ﬁbrous tissue is cellular with adipocytes scattered in
small clusters. Coursing throughout are prominent vascular
channels with plump endothelial cells.
Case 2: A solitary submucosal mass was detected on the
dorsal tongue of a 74 year old female. The lesion was
stated to be painful, appearing as a dome shaped nodule
with surface ulceration. The clinical impression was trau-
matic ﬁbroma versus granular cell tumor. The lesion was
excised and submitted for microscopic examination. The
excised specimen measured 1 9 7 9 4 cm and on hemi-
section a well deﬁned nodule was seen in the submucosa.
Microscopically, a single lobule of ﬁbrovascular tissue was
well delineated and partially encapsulated. The endothelial
element was found to be prominent with plump conspicu-
ous endothelial cells. Adipocytes were present as isolated
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element was hypocellular with mature sclerotic collagen
ﬁbers. (Fig. 1c, d).
Immunostaining demonstrated reactivity for factor VIII
in endothelial cells (Fig. 1e) and CD 34 was found in both
endothelial cells and ﬁbroblasts (Fig. 1f). S-100 protein
Fig. 1 Case 1. a Submucosal well demarcated, partially encapsulated
mass is comprised of ﬁbrovascular tissue (H&E, 509), b Numerous
prominent, plump endothelial cells line vessels in the background of a
bland hypercellular ﬁbroblastic element (H&E, 2009). Case 2. c
Demarcated mass comprised of multiple small prominent vessels,
zones of ﬁbroblastic cellularity with desmoplasia and pockets of
adipocytes (H&E, 509). d Higher magniﬁcation showing vascularity,
sclerosis and adipocytes (H&E, 2009). e Factor VIII immunoreac-
tivity in vessels (IHC/DAB, 2009). f CD34 immunoreactivity in both
endothelial cells and ﬁbroblasts (IHC/DAB, 2009)
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cell population (IHC/DAB).
Discussion
The microscopic differential diagnosis for CAF includes
angiomyolipoma, angiomyoﬁbroblastoma, juvenile naso-
pharyngeal angioﬁbroma, solitary ﬁbrous tumor, spindle
cell lipoma, and superﬁcial angiomyxoma [13–19]. All of
these lesions are vessel rich with a ﬁbroblastic or myoﬁb-
roblastic element, variable sclerosis and harbor focal
aggregates of adipocytes. Angiomyolipoma is a fatty tumor
with prominent muscular arterioles while angiomyoﬁbro-
blastoma is a ﬁbrovascular neoplasm with a loose,
somewhat myxoid ﬁbroblastic element. Juvenile nasopha-
ryngeal angioﬁbroma is uniquely conﬁned to the
nasopharynx and has a very distinct histology with a
homogeneous ﬁbroplasia and delicate immature collagen
with interposed sinusoidal-like vascular channels that lack
prominent endothelium. Solitary ﬁbrous tumors, comprised
of CD34 ﬁbroblasts are typically hypercellular, fasiculated
and do not exhibit prominent endothelial elements,
although some variants do in fact manifest a hemangio-
pericytoma-like pattern. Angiomyxomas of deep tissues are
aggressive neoplasms while superﬁcial lesions are non-
aggressive, may arise in the head and neck region as sub-
cutaneous nodules comprised of myxoid tissue with
prominent vascularity. These lesions may occur as a
component of the Carney complex. Whereas lipocytes are
commonly encountered in CAF, and were prominent in
case 2 reported here, they are compartmentalized and not
intimately interspersed with spindle cells as seen in spindle
cell lipoma. CAF shows a spectrum of histologic patterns
which may represent progressive stages of development
with more highly vascular and ﬁbrocellular lesions repre-
senting an early stage and less vascular more sclerotic
lesions being older. CAFs are well demarcated or partially
encapsulated, show hyperplastic vessels with prominent,
plump endothelial cells, and ﬁbroblastic hypercellularity.
The ﬁbrous element may also show mitotic activity with
typical mitotic ﬁgures.
Differentiation from reactive lesions such as pyogenic
granuloma or sclerosing pyogenic granuloma is usually not
problematical because these reactive lesions are diffuse or
multilobular, lacking the demarcation and encapsulation of
cellular angioﬁbroma. Furthermore, CAF is not inﬁltrated
by inﬂammatory cells unless superﬁcially ulcerated yet the
inﬂammation does not pervade the tumor stroma; rather
leukocytes are zonal, in continuity with the area of ulcer-
ation. CAF represents a unique lesion, common in the
gentital regions yet may occur in other sites including skin
and the head and neck area. In the series reported by Iwasa
and Fletcher [3], the ﬁbroblastic component of CAF may
be immunoreactive with antibodies to smooth muscle actin
and/or CD34. In the two cases reported here, CD34, yet not
SMA was positive in the ﬁbroblasts. Genetic studies dis-
close a relationship to spindle cell lipoma [17–21]. Simple
excision is the treatment of choice.
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